Drug Trial to Investigate the Safety and Efficacy of Niclosamide Tablets in Patients With Metastases of a Colorectal Cancer Progressing After Therapy

Study ID
NCT02519582

Study type
Interventional

Study phase
Phase 2

Study status
Unknown status

Trial Acronym

Nikolo

Trial Summary

Phase II trial evaluating the safety and efficacy of oral appliqued niclosamide in patients who are progressive with metachronous or synchronous metastases of colorectal cancer among the previous therapy (Nikolo). Monocentric open-label clinical trial of phase II. All patients received 2 g p.o. niclosamide daily until progression (according to RECIST) or unacceptable toxicity or discontinuation of study for other reasons.

More informations

Trial Starting Date

Aug 31,2015

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit